RGT 1.92% 26.5¢ argent biopharma limited

Ann: Agreement with SipNose takes MXC into Global Epilepsy Market, page-5

  1. 148 Posts.
    From the Sipnose Website:

    Collaborations


    At SipNose we collaborate with top of the line academic institutions and premier industry professionals to design and develop the next generation nasal delivery device and products. SipNose collaborates with thought leaders in CNS disease research, drug development and clinical research.

    Our technology enables drug molecules of vast chemical and pharmaceutical characteristics, to reach the brain faster and more efficient with higher safety and improved patient experience.

    SipNose platform can bridge the gap between a given CNS drug candidate (whether it is a small or large mollecule) and its efficacy and safety measures. Our innovative technology can be tailored to meet your needs.

    SipNose is seeking potential collaborations with pharmaceutical companies for the integration with the drug of interest.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
26.5¢
Change
0.005(1.92%)
Mkt cap ! $12.82M
Open High Low Value Volume
26.0¢ 26.5¢ 26.0¢ $46 174

Buyers (Bids)

No. Vol. Price($)
2 9236 26.0¢
 

Sellers (Offers)

Price($) Vol. No.
27.0¢ 12 1
View Market Depth
Last trade - 14.23pm 09/08/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.